This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Teglutik

Read time: 1 mins
Marketing start date: 26 Jan 2025

Summary of product characteristics


Effective Time

20240227

Version

1

Spl Product Data Elements

Teglutik Riluzole MAGNESIUM ALUMINUM SILICATE SORBITOL POLYOXYL 20 CETOSTEARYL ETHER WATER SACCHARIN SODIUM SILICON DIOXIDE DIMETHICONE SODIUM LAURYL SULFATE XANTHAN GUM RILUZOLE RILUZOLE slightly brown, opaque

Brand Name

Teglutik

Generic Name

Riluzole

Product Ndc

70726-0305

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PRINCIPAL DISPLAY PANEL - 300 mL Bottle Carton spanish label

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.